الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 130 |  |  |
| | | from | 130 | | |
Abstract
A major cause of cirrhosis-related morbidity and mortality is the development of variceal hemorrhage, Mortality during the first episode of variceal bleeding is estimated to 15– 20%, but is higher in severe patients, The Albumin /Bilirubin Score offers a simple, evidence-based, objective, and discriminatory method of assessing liver function that has been extensively tested in an international setting. Patients and Methods: This is a Case-control study that had done at the Hematemisis Unit at Mansoura University hospital. one hundred twenty cirrhotic patients (age range: 18–60 years). Those patients had liver cirrhosis admitted to hematemesis unit in Mansoura university hospital with first attack of variceal bleeding between March 2018 and March 2019 were selected for this study. Results: For prediction of mortality, sensitivity of ALBI ratio was 87.5% and specificity was 76.8%. The positive predictive value was 97.6%, while the negative predictive value was 38.9%. The accuracy was 80%. Regarding MELD score, sensitivity was 87.5% and specificity was 80.6%. The positive predictive value was 97.7%, while the negative predictive value was 41.2%. The accuracy was 81.7%. Regarding Child score, sensitivity was 75% and specificity was 84.6%. The positive predictive value was 95.7%, while the negative predictive value was 42.9% The accuracy was 83.3%. Conclusion: It is concluded from this study that ALBI score may be a reliable alternative prognostic model for assessing liver cirrhosis severity and assesing mortality risk in patients with variceal bleeding.